{"count":2,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/847b9a04-afce-4214-83bf-b8a64cce9546/","filing_uuid":"847b9a04-afce-4214-83bf-b8a64cce9546","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/847b9a04-afce-4214-83bf-b8a64cce9546/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Gary Gallant","dt_posted":"2026-07-20T12:47:52-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"2370 Champlain St NW ste 12","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20009","registrant":{"id":401105102,"url":"https://lda.gov/api/v1/registrants/401105102/","house_registrant_id":null,"name":"STUDENTS FOR SENSIBLE DRUG POLICY","description":"Drug policy reform advocacy","address_1":"2370 Champlain St NW ste 12","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20009","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KAT MURTI","contact_telephone":"+1 214-542-4056","dt_updated":"2026-07-14T21:09:50.477507-04:00"},"client":{"id":212030,"url":"https://lda.gov/api/v1/clients/212030/","client_id":12,"name":"STUDENTS FOR SENSIBLE DRUG POLICY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-07-01"},"lobbying_activities":[{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"Issues related to cannabis clemency. MARIJUANA OPPORTUNITY REINVESTMENT AND EXPUNGEMENT ACT (MORE) - H.R. 5068 - federally decriminalize cannabis by removing (descheduling) marijuana from the Controlled Substances Act, which would remove federal criminal penalties for its manufacture, distribution, or possession. STRENGTHENING THE TENTH AMENDMENT THROUGH ENTRUSTING STATES ACT (STATES 2.0) - H.R. 2934 - aligning federal law with state cannabis policies by exempting cannabis produced and sold in compliance with state law from the federal definition of \"marijuana.\" PREPARING REGULATORS EFFECTIVELY FOR A POST-PROHIBITION ADULT-USE REGULATED ENVIRONMENT ACT (PREPARE) - H.R. 2935 - S. 3576 - directing the Department of Justice to establish the Commission on the Federal Regulation of Cannabis to study a plausible and prompt pathway to cannabis regulation. EVIDENCE-BASED DRUG POLICY ACT - H.R. 3082 - repealing CSA restrictions on the Office of National Drug Control Policy (ONDCP) regarding the conducting of studies related to the legalization of a Schedule I substance. CLEAN SLATE ACT - H.R. 3114 - S. 1580 - sealing certain federal marijuana offenses and other certain nonviolent crimes after those with previous convictions after the completion of a sentence. MARIJUANA IN FEDERALLY ASSISTED HOUSING PARITY ACT - H.R. 6807 - S. 3537 - prohibiting the denial of occupancy of federally assisted housing on the basis of using, distributing, possessing, selling, or manufacturing marijuana in compliance with state law CANNABINOID SAFETY AND REGULATION ACT - S. 3474 - create a federal regulatory system for cannabinoid products (including hemp-derived consumer products). HEMP ENFORCEMENT MODERNIZATION, AND PROTECTION (HEMP) ACT - H.R. 7212 - establishing a nationwide age limit of 21 to purchase hemp-derived products. HEMP SAFETY ENFORCEMENT ACT - S. 4315 - permitting states and Indian tribes to opt out of the federal hemp production plan and new federal definition of hemp that would ban most hemp-derived THC products. AMERICAN HEMP PROTECTION ACT - H.R. 6209 - repealing the legislation set to take effect in November 2026 which would ban most hemp-derived THC products. HEMP PLANTING PREDICTABILITY ACT - H.R. 7024 - S. 3686 - postponing the effective date of the hemp ban by two years, from Nov. 12, 2026 to Nov. 12, 2028. It contains no additional regulatory provisions. The End Needless Distribution of 7-OH Act (H.R. 8000): restricting the distribution of synthetic 7-OH products by treating them as federally controlled substance with no accepted medical use. (OPPOSED)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145692,"prefix":null,"prefix_display":null,"first_name":"KAT","nickname":null,"middle_name":null,"last_name":"MURTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150093,"prefix":null,"prefix_display":null,"first_name":"GINA","nickname":null,"middle_name":null,"last_name":"GIORGIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"VETERANS CANNABIS USE FOR SAFE HEALING ACT - H.R. 966 - to prohibit the Department of Veterans Affairs (VA) from denying a veteran any VA benefit due to participation in a state-approved marijuana program. VETERANS EQUAL ACCESS ACT - H.R. 1384 - requiring the VA to authorize its physicians to complete forms for veterans, thereby increasing efficiency and reducing out of pocket costs for veterans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145692,"prefix":null,"prefix_display":null,"first_name":"KAT","nickname":null,"middle_name":null,"last_name":"MURTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/bc5e1b22-11f0-4d4f-afeb-fd3faf09962a/","filing_uuid":"bc5e1b22-11f0-4d4f-afeb-fd3faf09962a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/bc5e1b22-11f0-4d4f-afeb-fd3faf09962a/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":"A","expenses_method_display":"A","posted_by_name":"Gary Gallant","dt_posted":"2026-10-19T22:04:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"2370 Champlain St NW ste 12","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20009","registrant":{"id":401105102,"url":"https://lda.gov/api/v1/registrants/401105102/","house_registrant_id":null,"name":"STUDENTS FOR SENSIBLE DRUG POLICY","description":"Drug policy reform advocacy","address_1":"2370 Champlain St NW ste 12","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20009","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KAT MURTI","contact_telephone":"+1 214-542-4056","dt_updated":"2026-07-14T21:09:50.477507-04:00"},"client":{"id":212030,"url":"https://lda.gov/api/v1/clients/212030/","client_id":12,"name":"STUDENTS FOR SENSIBLE DRUG POLICY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-07-01"},"lobbying_activities":[{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"Issues related to cannabis clemency. MARIJUANA OPPORTUNITY REINVESTMENT AND EXPUNGEMENT ACT (MORE) - H.R. 5068 - federally decriminalize cannabis by removing (descheduling) marijuana from the Controlled Substances Act, which would remove federal criminal penalties for its manufacture, distribution, or possession. STRENGTHENING THE TENTH AMENDMENT THROUGH ENTRUSTING STATES ACT (STATES 2.0) - H.R. 2934 - aligning federal law with state cannabis policies by exempting cannabis produced and sold in compliance with state law from the federal definition of \"marijuana.\" PREPARING REGULATORS EFFECTIVELY FOR A POST-PROHIBITION ADULT-USE REGULATED ENVIRONMENT ACT (PREPARE) - H.R. 2935 - S. 3576 - directing the Department of Justice to establish the Commission on the Federal Regulation of Cannabis to study a plausible and prompt pathway to cannabis regulation. EVIDENCE-BASED DRUG POLICY ACT - H.R. 3082 - repealing CSA restrictions on the Office of National Drug Control Policy (ONDCP) regarding the conducting of studies related to the legalization of a Schedule I substance. CLEAN SLATE ACT - H.R. 3114 - S. 1580 - sealing certain federal marijuana offenses and other certain nonviolent crimes after those with previous convictions after the completion of a sentence. MARIJUANA IN FEDERALLY ASSISTED HOUSING PARITY ACT - H.R. 6807 - S. 3537 - prohibiting the denial of occupancy of federally assisted housing on the basis of using, distributing, possessing, selling, or manufacturing marijuana in compliance with state law CANNABINOID SAFETY AND REGULATION ACT - S. 3474 - create a federal regulatory system for cannabinoid products (including hemp-derived consumer products). HEMP ENFORCEMENT MODERNIZATION, AND PROTECTION (HEMP) ACT - H.R. 7212 - establishing a nationwide age limit of 21 to purchase hemp-derived products. HEMP SAFETY ENFORCEMENT ACT - S. 4315 - permitting states and Indian tribes to opt out of the federal hemp production plan and new federal definition of hemp that would ban most hemp-derived THC products. AMERICAN HEMP PROTECTION ACT - H.R. 6209 - repealing the legislation set to take effect in November 2026 which would ban most hemp-derived THC products. HEMP PLANTING PREDICTABILITY ACT - H.R. 7024 - S. 3686 - postponing the effective date of the hemp ban by two years, from Nov. 12, 2026 to Nov. 12, 2028. It contains no additional regulatory provisions. The End Needless Distribution of 7-OH Act (H.R. 8000): restricting the distribution of synthetic 7-OH products by treating them as federally controlled substance with no accepted medical use. (OPPOSED)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145692,"prefix":null,"prefix_display":null,"first_name":"KAT","nickname":null,"middle_name":null,"last_name":"MURTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"VETERANS CANNABIS USE FOR SAFE HEALING ACT - H.R. 966 - to prohibit the Department of Veterans Affairs (VA) from denying a veteran any VA benefit due to participation in a state-approved marijuana program. VETERANS EQUAL ACCESS ACT - H.R. 1384 - requiring the VA to authorize its physicians to complete forms for veterans, thereby increasing efficiency and reducing out of pocket costs for veterans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145692,"prefix":null,"prefix_display":null,"first_name":"KAT","nickname":null,"middle_name":null,"last_name":"MURTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}